NIAID Site Search

Background information and profile of NIAID Director, Anthony S. Fauci, M.D.

Last Reviewed: March 21, 2025

Published: April 5, 2023

I am announcing today that I will be stepping down from the positions of Director of the National Institute of Allergy and Infectious Diseases (NIAID) and Chief of the NIAID Laboratory of Immunoregulation, as well as the position of Chief Medical Advisor to President Joe Biden. I will be leaving these positions in December of this year to pursue the next chapter of my career.

Published: August 22, 2022

Today, Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and Chief Medical Advisor to President Biden, tested positive for COVID-19 on a rapid antigen test. He is fully vaccinated and has been boosted twice. He is currently experiencing mild symptoms. Dr. Fauci will isolate and continue to work from his

Published: June 15, 2022

NIH’s Advisory Committee to the Director (ACD) provides recommendations on program development, resource allocation, NIH administrative regulation, and other aspects of NIH policy.

Published: February 1, 2023

Dr. Fauci testimony slides: The Role of the National Institute of Allergy and Infectious Diseases in Research Addressing Zika Virus May 2016

Last Reviewed: May 12, 2016

Once considered a potentially static field of medicine, the discipline of studying infectious diseases has proven to be dynamic as emerging and reemerging infectious diseases present continuous challenges, Anthony S. Fauci, M.D., writes in a perspective in The New England Journal of Medicine. In the piece, Dr. Fauci, who since 1984 has directed the National Institute of Allergy and Infectious

Published: November 28, 2022

Resources about the fascinating life of Dr. Joseph J. Kinyoun, the Father of the NIH.

Last Reviewed: November 14, 2012

A list of previous NIAID Directors and Deputy Directors including current Director Anthony S. Fauci, M.D.

Last Reviewed: October 2, 2024

In his remarks to NIAID’s Advisory Council, NIAID Director Dr. Anthony Fauci shared key staff transitions, legislative updates, and COVID-19 news.

Published: March 3, 2021

David M. Morens, M.D. 1* Victoria A. Harden, Ph.D. 2 Joseph Kinyoun Houts, Jr. 3 Anthony S. Fauci, M.D. 4 _____________________________________________________________________ 1 Senior Advisor to the NIAID Director, NIH 2 Founding Director and Special Volunteer, Office of NIH History and Stetten Museum 3 St. Joseph, Missouri 4 Director, NIAID, NIH * Address correspondence to David M. Morens

Last Reviewed: August 28, 2012

Lessons learned from the public health responses to the HIV and COVID-19 pandemics should help guide the response to the current outbreak of monkeypox, National Institutes of Health experts write in an editorial published today in the New England Journal of Medicine. Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID), and H. Clifford Lane, M.D

Published: August 24, 2022

Background information about previous NIAID director James C. Hill, Ph.D.

Last Reviewed: May 8, 2018

Hearing of the House Committee on Energy and Commerce, Subcommittee on Health: The Role of the NIAID in Reserch Addressing Ebola Virus Distease- Dr. Fauci November 2014

Last Reviewed: August 6, 2019

The emergence and rapid increase in cases of coronavirus disease 2019 (COVID-19), a respiratory illness caused by a novel coronavirus, pose complex challenges to the global public health, research and medical communities, write federal scientists from NIH’s National Institute of Allergy and Infectious Diseases (NIAID) and from the Centers for Disease Control and Prevention (CDC). Their commentary

Published: February 28, 2020

The Role of NIAID in Research Addressing Ebola Virus Disease Testimony before the House Appropriations Committee, Subcommittee on Labor, Health and Human Services, Education, and Related Agencies- Dr. Fauci April 2015

Last Reviewed: August 6, 2019

The COVID-19 pandemic is affecting people with or at risk for HIV both indirectly, by interfering with HIV treatment and prevention services, and directly, by threatening individual health. An effective response to these dual pandemics requires unprecedented collaboration to accelerate basic and clinical research, as well as implementation science to expeditiously introduce evidence-based

Published: April 8, 2021

Achieving classical herd immunity against SARS-CoV-2, the virus that causes COVID-19, may not be attainable, according to a new perspective published in The Journal of Infectious Diseases. However, widespread use of currently available public health interventions to prevent and control COVID-19 will enable resumption of most activities of daily life with minimal disruption.

Published: March 31, 2022

NIAID Director Dr. Anthony Fauci discussed topics like budget and legislation, and Dr. John Mascola, director of the Vaccine Research Center (VRC), described VRC's work on mRNA and therapeutic antibodies related to COVID-19 as well as on influenza vaccines.

Published: July 7, 2021

The Role of NIAID in Research Addressing Zika Virus: Hearing of the Senate Health, Education, Labor, and Pensions Committee February 24, 2016

Last Reviewed: August 6, 2019

Cover and Table of Contents The Jordan Report: Accelerated Development of Vaccines 2012, published by NIAID, includes expert articles on a variety of vaccine-related topics and updates on vaccine research for specific infectious diseases. Foreword and Tributes The 30th anniversary version of the Report, which highlights recent advances in vaccine research, is prefaced by a foreword by NIAID

Last Reviewed: April 3, 2012